- Home
- TOP vs LTRN Comparison
TOP vs LTRN Comparison
Compare TOP & LTRN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | TOP | LTRN |
|---|---|---|
| Founded | 2015 | 2013 |
| Country | Singapore | United States |
| Employees | N/A | N/A |
| Industry | Investment Bankers/Brokers/Service | Biotechnology: Pharmaceutical Preparations |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 43.0M | 49.9M |
| IPO Year | 2022 | 2020 |
Fundamental Metrics
Financial Performance| Metric | TOP | LTRN |
|---|---|---|
| Price | $1.15 | $3.60 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 1 |
| Target Price | N/A | ★ $25.00 |
| AVG Volume (30 Days) | 46.8K | ★ 71.4K |
| Earning Date | 01-26-2026 | 11-12-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | ★ $3,329,256.00 | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $1.00 | $2.55 |
| 52 Week High | $3.33 | $6.12 |
Technical Indicators
Market Signals| Indicator | TOP | LTRN |
|---|---|---|
| Relative Strength Index (RSI) | 54.02 | 47.80 |
| Support Level | $1.10 | $3.72 |
| Resistance Level | $1.24 | $3.98 |
| Average True Range (ATR) | 0.05 | 0.27 |
| MACD | 0.02 | 0.04 |
| Stochastic Oscillator | 59.09 | 48.72 |
Price Performance
Historical ComparisonAbout TOP TOP Financial Group Limited
TOP Financial Group Ltd is an online brokerage firm in Hong Kong specializing in trading local and overseas equities, futures, and options products. The Company generates brokerage commission income by enabling its customers to trade on multiple exchanges present globally. The company operates in only one segment which is the futures brokerage service.
About LTRN Lantern Pharma Inc.
Lantern Pharma Inc is an AI company transforming the cost, pace, and timeline of oncology drug discovery and development. Its proprietary AI and machine learning (ML) platform, RADR, uses oncology-focused data points and advanced ML algorithms to solve billion-dollar, real-world problems in cancer drug development. The group's growing pipeline of precision therapies has been accelerated using AI and input from world-class scientific advisors and collaborators.